Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Group 1 - The discussion focuses on the current state of the company and its evolution under new leadership [1] - There is an emphasis on analyzing new disclosures from Q3 related to clinical developments [1] - The conversation includes recent developments, policy issues in China, and competitive dynamics [1] - There is an intention to discuss future outlook for 2026 and beyond [1]